Free Trial

→ Market down? Do this now. (From Colonial Metals) (Ad)

15 Stocks That Insiders Won't Stop Buying - 8 of 15

Slide 8

TriSalus Life Sciences (NASDAQ:TLSI)

Dollar Amount of Shares Purchased: $639,797.06
Number of Insider Purchases in the Last 180 Days: 10
Volume of Shares Purchased: 137,388
Who Bought Shares: Equity Ab Frankenius (Major Shareholder), James Emmett Young (CFO), Mary T Szela (CEO), Mats Wahlstrom (Director) and Sean Murphy (Insider)

Insider Trades by Quarter for TriSalus Life Sciences (NASDAQ:TLSI)

About TriSalus Life Sciences

TriSalus Life Sciences, Inc, a medical technology company, researches, develops, and sells drug delivery technologies and immune-oncology therapeutics for the treatment of liver and pancreatic cancer. The company offers Pressure Enabled Drug Delivery infusion systems, such as the TriNav infusion system, which is used in transarterial radioembolization and chemoembolization procedures for patients with liver cancer and metastases; and the Pancreatic Retrograde Venous Infusion device, which is in Phase 1 clinical trial, for locally advanced pancreatic cancer. More

Slide 8

More From MarketBeat

web analytics

Get 30 Days of MarketBeat All Access for Free

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools.

Start Your 30-Day Trial

Sign in to your free account to enjoy these benefits

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign in to your free account to enjoy all that MarketBeat has to offer.

Sign In
Create Account

Your Email Address:

Your Password:

Log In

or

Sign in with Google

Forgot your password?

Your Email Address:

Choose a Password:

or

Sign in with Google

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.